JnJ bags USFDA nod for Akeega plus prednisone for BRCA2 mutated metastatic castration sensitive prostate cancer

Day 1 conference highlights include news from Moderna, BridgeBio

DRRA14 hours ago 0

FDA again rejects tabelecleucel for EBV-driven post-transplant lymphoproliferative disease

DRRA14 hours ago 0

New data, nuances in managing resistant gram-negative infections

DRRA16 hours ago 0

New Year’s resolutions 2026: Lessons from colleagues

DRRA16 hours ago 0